| Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections RK Shields, AJ Dorazio, G Tiseo, KM Squires, A Leonildi, C Giordano, ... JAC-Antimicrobial Resistance 6 (5), dlae146, 2024 | | 2024 |
| Evaluation of Klebsiella pneumoniae pathogenicity through holistic gene content analysis M Isogai, K Kawamura, T Yagi, S Kayama, M Sugai, Y Doi, M Suzuki Microbial Genomics 10 (9), 001295, 2024 | | 2024 |
| Increased mortality in hospital-compared to community-onset carbapenem-resistant enterobacterales infections AE Boutzoukas, N Mackow, A Giri, L Komarow, C Hill, L Chen, Y Doi, ... Journal of Antimicrobial Chemotherapy, dkae306, 2024 | | 2024 |
| Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial H Yotsuyanagi, N Ohmagari, Y Doi, M Yamato, A Fukushi, T Imamura, ... Antiviral Research 229, 105958, 2024 | 1 | 2024 |
| Evolution of extended-spectrum β-lactamase-producing ST131 Escherichia coli at a single hospital over 15 years ST Cho, EG Mills, MP Griffith, HR Nordstrom, CL McElheny, LH Harrison, ... Scientific Reports 14 (1), 19750, 2024 | | 2024 |
| Pseudomonas aeruginosa Lipid A Structural Variants Induce Altered Immune Responses CE Hofstaedter, IP O’Keefe, CM Met, L Wu, J Vanderwoude, S Shin, ... American journal of respiratory cell and molecular biology 71 (2), 207-218, 2024 | 1 | 2024 |
| Clinical Impacts of Allograft Biopsy in Renal Transplant Recipients 10 Years or Longer After Transplantation T Namba-Hamano, T Hamano, Y Doi, A Hiraoka, H Yonishi, S Sakai, ... Transplant International 37, 13022, 2024 | | 2024 |
| Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales G Weston, A Giri, L Komarow, L Ge, KR Baum, E Abbenante, ... Journal of Antimicrobial Chemotherapy, dkae186, 2024 | | 2024 |
| Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan R Hase, A Sakurai, M Suzuki, N Itoh, K Hayakawa, K Uemura, ... Journal of Antimicrobial Chemotherapy, dkae168, 2024 | | 2024 |
| Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID‐19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial N Ohmagari, H Yotsuyanagi, Y Doi, M Yamato, T Imamura, H Sakaguchi, ... Influenza and Other Respiratory Viruses 18 (6), e13338, 2024 | | 2024 |
| Host stress hormone norepinephrine reduces in vitro activity of aminoglycoside against carbapenemase-producing Enterobacterales M Inaba, Y Doi Journal of Antimicrobial Chemotherapy 79 (6), 1468-1470, 2024 | | 2024 |
| How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand‐Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic M Sasaki, H Sato, Y Uemura, A Mikami, N Ichihara, S Fujitani, M Kondo, ... Clinical Pharmacology & Therapeutics 115 (6), 1372-1382, 2024 | | 2024 |
| Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality K Hattori, Y Sakaguchi, T Oka, Y Asahina, T Kawaoka, Y Doi, ... Journal of the American Society of Nephrology, 10.1681, 2024 | 1 | 2024 |
| Outbreak of Streptococcus pyogenes emm89 ST646 in a head and neck surgical oncology ward B Hayama, S Harada, M Suzuki, Y Doi, Y Nomura, K Aoki, K Takehana, ... Microbiology Spectrum 12 (5), e04260-23, 2024 | | 2024 |
| Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae D Suzuki, A Sakurai, M Wakuda, M Suzuki, Y Doi Antimicrobial Agents and Chemotherapy 68 (5), e01672-23, 2024 | 1 | 2024 |
| # 410 Novel renal pathology and treatment of TIN with monoclonal plasma cells invasion in a patient with Sjögren's syndrome and IgA monoclonal gammopathy A Hesaka, Y Hirata, T Kubota, S Sakai, Y Doi, T Namba-Hamano, ... Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-1263-410, 2024 | | 2024 |
| Mutations Drive Increased Elastase Activity in Pseudomonas Aeruginosa Clinical Isolates SE Fernandes, C McElheny, Y Doi, M Nouraie, J Lee, P Jorth C107. MICROBIAL RESPIRATORY INFECTIONS DISCOVERIES, A6812-A6812, 2024 | | 2024 |
| Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosa L Wang, X Zhou, Y Lu, X Zhang, J Jiang, Z Sun, M Yin, Y Doi, M Wang, ... International Journal of Antimicrobial Agents 63 (5), 107119, 2024 | | 2024 |
| Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates KJ Westbrook, GS Chilambi, ME Stellfox, HR Nordstrom, Y Li, A Iovleva, ... Journal of Antimicrobial Chemotherapy 79 (4), 801-809, 2024 | | 2024 |
| Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2 M Nakagawa, Y Fujishiro, Y Doi, J Yamakami, H Honda Infection Control & Hospital Epidemiology, 1-3, 2024 | | 2024 |
